Mayne Pharma Australia
Jana Wallace-Blair possesses extensive experience in analytical development with a career spanning over two decades, primarily at Mayne Pharma where responsibilities have included roles as Analytical Development Team Leader, Senior Analytical Development Chemist, and Analytical Chemist since 2011. Currently, as Analytical Development Team Coordinator at Mayne Pharma Services, Jana develops, validates, and transfers analytical methods while ensuring compliance with cGMP and regulatory standards. Previous experience includes working at Mayne Pharma International from 2004 to 2011 and serving as a Polling Official for the Australian Electoral Commission from 2001 to 2010. Jana holds a Bachelor of Technology in Forensic and Analytical Chemistry from Flinders University and a Certificate IV in Training and Assessment from ASC Training and Development Pty Ltd.
This person is not in the org chart
This person is not in any teams
Mayne Pharma Australia
2 followers
Mayne Pharma is an ASX (MYX) listed specialty pharmaceutical company with operations in Australia and the USA. Mayne Pharma International (MPI) is headquartered in Adelaide, South Australia. Our Australian based division offers a full-service CDMO with expertise in pharmaceutical development and scale up from concept to commercialisation, quickly and cost effectively. Our GMP manufacturing facility is TGA and FDA accredited, licensed to handle various scheduled drugs and are well positioned to provide a gateway to global markets. We use our unique oral drug delivery systems to improve formulations and in-license novel medicines from around the world. Through innovation and collaborative partnerships, our products address unmet clinical needs for Australians. Our commercial function in Australia covers a range of speciality prescription and consumer products and is supported by our national team. We are committed to delivering better health outcomes for Australian patients.